Bioflavonoid hesperidin possesses the anti-hyperglycemic and hypolipidemic property in STZ induced diabetic myocardial infarction (DMI) in male Wister rats
-
Add time:08/16/2019 Source:sciencedirect.com
The aim of our study was to evaluate the hesperidin anti-hyperglycemic and hypo-lipidemic effects on diabetic myocardial infraction (DMI) rats by decreasing the blood glucose and blood cholesterol contents. The object of the study was to examine the 7groups of male Wistar rats, each group contains 6 rats, Group I (normal), Group II diabetic (control) and 5(experimental) groups, i.e., Group III (diabetic + hesperidin), Group IV (diabetic + Glibenclamide), Group V (ISO), Group VI (diabetic + ISO) and Group VII (diabetic + ISO + hesperidin). By that intake of hesperidin regulates the lipid and carbohydrate metabolism by decreasing the cholesterols in blood and plasma insulin by hyperlipidamic and anti-hyperglycemic activity. The rats turns to diabetic with single intraperitonial STZ injection (50 mg/kg BW), and from the second week the rats diet were switched to a high fat diet, i.e., cholesterol (40%), fat (50%), Protein (50%) turns to be hyperlipidamic rats and with Isoproterenol (ISO) single intraperitoneal injection by the (11 mg/kg BW) turns to DMI rats. The DMI rats fed with the hesperidin 100mg/kg BW for 4 weeks had significantly reduced the blood glucose (P < 0.05), total cholesterol (TC), Triglycerides, HDL, LDL and VLDL concentrations, when compared with experimental groups (p < 0.05). A significantly increased blood glucose and body weight was observed in hesperidin treated diabetic groups (P < 0.05) by comparing with the experimental groups. In conclusion, orally supplementation of hesperidin possesses a significant decrease in total blood lipid profiles and plasma insulin concentrations accompanied by the anti-hyperglycemic, hypo-lipidemic activity in DMI rats.
We also recommend Trading Suppliers and Manufacturers of Methyl hesperidin (cas 11013-97-1). Pls Click Website Link as below: cas 11013-97-1 suppliers
Prev:Molecular spectroscopic on interaction between Methyl hesperidin (cas 11013-97-1) and Buman serum albumin
Next:Egg proteins stabilized green silver nanoparticles as delivery system for hesperidin enhanced bactericidal potential against resistant S. aureus) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Protective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice: Role of TRPV1, oxidative stress, cytokines and NF-κB08/20/2019
- Subchronic toxicity study of Methyl hesperidin (cas 11013-97-1) in mice08/19/2019
- Amelioration effect of Egyptian sweet orange hesperidin on Ehrlich ascites carcinoma (EAC) bearing mice08/18/2019
- Egg proteins stabilized green silver nanoparticles as delivery system for hesperidin enhanced bactericidal potential against resistant S. aureus08/17/2019
- Molecular spectroscopic on interaction between Methyl hesperidin (cas 11013-97-1) and Buman serum albumin08/15/2019
- Development of nobiletin–Methyl hesperidin (cas 11013-97-1) amorphous solid dispersion: Novel application of Methyl hesperidin (cas 11013-97-1) as an excipient for hot-melt extrusion08/14/2019
-
Health and Chemical more >
-
Related Products
- Hesperidin methylchalcone
- Methyl 1-Benzyl-5-oxopyrrolidine-3-carboxylate
- Methyl (((methoxymethylphosphinothioyl)thio)acetyl)methylcarbamate
- Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-(6E)-heptenoate
- Methyl (2-amino-5-methyl-1,3-thiazol-4-yl)acetate
- Methyl (2-chloromethyl)oxazole-4-carboxylate
- Methyl (2E)-3-(4-methylphenyl)propenoate
- Methyl (2E)-3-cyclohexylprop-2-enoate
- Methyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-iodopropanoate
- Methyl (2R)-2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate


